Trial Profile
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Evaluation of the Safety and Analgesic Efficacy of COV155 Tablets in Moderate to Severe Post-Operative Bunionectomy Pain Followed by an Open-Label Extension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2014
Price :
$35
*
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Mallinckrodt Inc.
- 05 Sep 2014 Results were presented at PAINWeek 2014, according to a Mallinckrodt media release
- 03 May 2014 Results presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 13 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.